Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Pharmacodynamics of Janus kinase inhibitors for the treatment of atopic dermatitis

Published:2022-05-04 Issue:5 Volume:18 Page:347-355
ISSN:1742-5255
Container-title:Expert Opinion on Drug Metabolism & Toxicology
language:en
Short-container-title:Expert Opinion on Drug Metabolism & Toxicology

Author:

Calabrese Laura¹²^ORCID,Chiricozzi Andrea¹²^ORCID,De Simone Clara¹²,Fossati Barbara¹,D’Amore Alessandra¹,Peris Ketty¹²^ORCID

Affiliation:

1. Chirurgiche, Fondazione Policlinico Universitario A. Gemelli - IRCCSUOC di Dermatologia, Dipartimento di Scienze Mediche e , Rome, Italy

2. Chirurgia Traslazionale, Università Cattolica del Sacro CuoreDermatologia, Dipartimento di Medicina e , Rome, Italy

Publisher

Informa UK Limited

Subject

Pharmacology,Toxicology,General Medicine

Link

https://www.tandfonline.com/doi/pdf/10.1080/17425255.2022.2099835

Reference99 articles.

1. Public Health Burden and Epidemiology of Atopic Dermatitis

2. Atopic Dermatitis: Pathophysiology

3. Atopic Dermatitis: Global Epidemiology and Risk Factors

4. Filaggrin Mutations Associated with Skin and Allergic Diseases

5. Meta-analysis of genome-wide association studies identifies three new risk loci for atopic dermatitis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy, Safety, and Early Relapse After Cessation of Upadacitinib Versus Dupilumab in Adolescents with Moderate-to-Severe Atopic Dermatitis: A Real-World Study in China;Dermatitis®;2024-08-20

2. Case report: Psoriasiform eczema with immune-mediated comorbidities treated with upadacitinib;Frontiers in Immunology;2024-08-05

3. Blocking the IL-4/IL-13 Axis versus the JAK/STAT Pathway in Atopic Dermatitis: How Can We Choose?;Journal of Personalized Medicine;2024-07-22

4. Therapeutic Potential of Targeting the JAK/STAT Pathway in Psoriasis: Focus on TYK2 Inhibition;Journal of Clinical Medicine;2024-05-24

5. Metabolic effects of upadacitinib in patients with psoriasis and atopic dermatitis;Archives of Dermatological Research;2024-05-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3